Anti-Human CD19 Antibody [4G7]
Anti-Human CD19 Antibody [4G7] with collaborator-tested evidence for Flow Cyt. Read more ›
![Human peripheral blood lymphocytes were stained with 0.2 μg AF/LE Purified Anti-Human CD19 Antibody[4G7] (Right) and 0.2 μg Mouse IgG1, κ Isotype Control (Left), followed by APC-conjugated Goat Anti-Mouse IgG Secondary Antibody, then anti-Human CD22 PE-conjugated Monoclonal Antibody.](http://www.abmium.com/cdn/shop/files/RxLKhD.jpg?v=1780770580&width=900)
![Human peripheral blood lymphocytes were stained with 0.2 μg AF/LE Purified Anti-Human CD19 Antibody[4G7] (Right) and 0.2 μg Mouse IgG1, κ Isotype Control (Left), followed by APC-conjugated Goat Anti-Mouse IgG Secondary Antibody, then anti-Human CD22 PE-conjugated Monoclonal Antibody.](http://www.abmium.com/cdn/shop/files/RxLKhD.jpg?v=1780770580&width=160)
["FCM"]Product Description
CD19 is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Mouse; clonality: Monoclonal; clone: 4G7; isotype: Mouse IgG1, κ; available conjugation options: None (AF/LE), Unconjugated, PE/Cyanine 7, Elab Fluor®700, PE/Elab Fluor®594, Elab Fluor®Violet 450.
Application evidence: Elabscience lists this product for FCM. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Recombinant Human CD19 protein; purification: >98%, Protein A/G purified; concentration: ≥ 1 mg/mL.
Database references: UniProt: P15391 | NCBI Gene: 930.
Research Use Only.
Key Facts
| Target | CD19 |
| Also known as | CVID, B-lymphocyteantigenCD, B-lymphocyte antigen CD, T-cellsurfaceantigenLeu, Differentiation antigen CD, T-cell surface antigen Leu, B-lymphocytesurfaceantigenB, B-lymphocyte surface antigen B, B4, CVID3, CD19, B-lymphocyteantigenCD19, B-lymphocytesurfaceantigenB4, T-cellsurfaceantigenLeu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, Differentiation antigen CD19, T-cell surface antigen Leu-12, B4, CVID3, CD19, CD19 molecule |
| Concentration | ≥ 1 mg/mL |
| Species reactivity | Human |
| Purity | >98% |
| Shelf life | 12 months from shipping dates |
| Research area | Immunology, Stem Cells |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | |
|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.